2-Pyrrolidone → HCID 71252276, compound

HRID 2412067Notes

Reaction equation

Br[C:2]1[CH:3]=[CH:4][C:5]([C:10]([N:12]2[CH2:17][CH2:16][N:15]([C:18]3[C:23]([CH3:24])=[CH:22][C:21]([CH2:25][CH3:26])=[CH:20][N:19]=3)[CH2:14][CH2:13]2)=[O:11])=[C:6]([CH:9]=1)[C:7]#[N:8].[NH:27]1[CH2:31][CH2:30][CH2:29][C:28]1=[O:32]>>[CH2:25]([C:21]1[CH:22]=[C:23]([CH3:24])[C:18]([N:15]2[CH2:16][CH2:17][N:12]([C:10]([C:5]3[CH:4]=[CH:3][C:2]([N:27]4[CH2:31][CH2:30][CH2:29][C:28]4=[O:32])=[CH:9][C:6]=3[C:7]#[N:8])=[O:11])[CH2:13][CH2:14]2)=[N:19][CH:20]=1)[CH3:26]

Participants

Reactant 2

HCID 120252-Pyrrolidone

HCID 71252298HCID 71252298, compound

Product 1

HCID 71252276HCID 71252276, compound

Procedure

Using 5-bromo-2-[4-(5-ethyl-3-methylpyridin-2-yl)piperazine-1-carbonyl]benzonitrile (827 mg) described in Preparation Example 246 and pyrrolidin-2-one (230 μL) and by the reaction and treatment in the same manner as in Example 262, the title compound (817 mg) was obtained.

Sources & evidence

ORD record: ord-c38c5244153b437bb3a7336005cf708d
Source dataset: uspto-grants-2014_08
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US08816079B2

Reaction notes

Loading…